Researchers from Stanford University have developed a new diagnostic tool that can detect genetic mutations in small amounts of tumor-derived DNA circulating in a patient’s blood sample.
The single color digital PCR assay needs a fraction of a tube of blood and can successfully detect three mutation-bearing molecules in a single reaction, according to the report published in The Journal of Molecular Diagnostics.
Get the full story at our sister site, Drug Delivery Business News.